MACROGENICS, INC. Tax Withholding Paid on Stock Awards
MACROGENICS, INC. (MGNX) reported Tax Withholding Paid on Stock Awards of $218.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-14
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00.
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $218.00K, a 22.70% decline year-over-year.
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $6.00K, a 50.00% increase year-over-year.
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $288.00K, a 88.36% decline from fiscal 2024.
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $2.48M, a 708.82% increase from fiscal 2023.
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $306.00K.
- MACROGENICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $218.00K 10-Q · filed 2026-08-14 | $224.00K derived: sum of 3 quarters · filed 2026-08-14 | $224.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $218.00K 10-Q · filed 2026-05-13 | $224.00K derived: sum of 2 quarters · filed 2026-05-13 | $224.00K derived: sum of 3 quarters · filed 2026-05-13 | $224.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $6.00K derived: sum of 2 quarters · filed 2026-03-09 | $6.00K derived: sum of 3 quarters · filed 2026-08-14 | $288.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $282.00K 10-Q · filed 2025-11-12 | $286.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $282.00K 10-Q · filed 2026-08-14 | $286.00K derived: sum of 3 quarters · filed 2026-08-14 | $360.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $282.00K 10-Q · filed 2026-05-13 | $286.00K derived: sum of 2 quarters · filed 2026-05-13 | $360.00K derived: sum of 3 quarters · filed 2026-05-13 | $366.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $78.00K derived: sum of 2 quarters · filed 2026-03-09 | $84.00K derived: sum of 3 quarters · filed 2026-03-09 | $2.48M 10-K · filed 2026-03-09 |
| 2024-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $80.00K derived: sum of 2 quarters · filed 2025-11-12 | $2.47M 10-Q · filed 2025-11-12 | $2.47M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.40M 10-Q · filed 2025-08-14 | $2.40M derived: sum of 3 quarters · filed 2026-03-09 | $2.54M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $2.39M 10-Q · filed 2025-05-13 | $2.39M derived: sum of 2 quarters · filed 2026-03-09 | $2.53M derived: sum of 3 quarters · filed 2026-03-09 | $2.54M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $141.00K derived: sum of 2 quarters · filed 2026-03-09 | $148.00K derived: sum of 3 quarters · filed 2026-03-09 | $306.00K 10-K · filed 2026-03-09 |
| 2023-09-30 | $141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $148.00K derived: sum of 2 quarters · filed 2024-11-05 | $306.00K 10-Q · filed 2024-11-05 | $292.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $165.00K 10-Q · filed 2024-08-06 | $151.00K derived: sum of 3 quarters · filed 2025-03-20 | $165.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-03-31 | $158.00K 10-Q · filed 2024-05-09 | $144.00K derived: sum of 2 quarters · filed 2025-03-20 | $158.00K derived: sum of 3 quarters · filed 2025-03-20 | $158.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2022-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 |
| 2022-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $14.00K derived: sum of 2 quarters · filed 2023-11-06 | $14.00K 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | $1.56M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.01M 10-K · filed 2021-02-25 | ||
| 2020-09-30 | $2.01M 10-Q · filed 2021-11-02 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 | |||
| 2018-12-31 | $260.00K 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $40.00K 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $39.00K 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $29.00K 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $19.00K 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |